These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8738851)

  • 1. Clinical experience with the fourth generation cephalosporins.
    Giamarellou H
    J Chemother; 1996 Feb; 8 Suppl 2():91-104. PubMed ID: 8738851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefpirome: efficacy in the treatment of urinary and respiratory tract infections and safety profile.
    Norrby SR
    Scand J Infect Dis Suppl; 1993; 91():41-50. PubMed ID: 8290902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dosage cefepime as treatment for serious bacterial infections.
    Giamarellou H
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():123-32. PubMed ID: 8150755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL; Foster RH; Benfield P
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of cefpirome in the treatment of complicated infections of the upper and lower urinary tracts].
    Derevianko II; Kotliarova GA; Kondrat'eva EM; Khodyreva LA; Siniukhin VN
    Antibiot Khimioter; 1996; 41(12):30-3. PubMed ID: 9124983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of cefepime (BMY 28142) to treat respiratory infections.
    Clynes N; Scully BE; Neu HC
    Diagn Microbiol Infect Dis; 1989; 12(3):257-60. PubMed ID: 2791488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical trial of a new broad-spectrum cephalosporin: HR 756 (cefotaxime)].
    Poletti T; Bertola D; Pellerito R; Soragna A
    Minerva Med; 1980 Jul; 71(27):1935-43. PubMed ID: 6248823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime in the treatment of complicated respiratory and urinary tract infections.
    Loebis LH; Williams KJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():59-64. PubMed ID: 6352656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftazidime in clinical practice.
    Alestig K; Eilard T; Norrby R; Svensson R; Trollfors B; Brorson JE
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():111-4. PubMed ID: 6225759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteriological and clinical evaluation of cephalosporin preparations in 10 years of experience].
    Catalano G; Abbate GF; Gattoni A; Coraggio F; Altucci P
    G Ital Chemioter; 1977; 24(1-2):39-48. PubMed ID: 615761
    [No Abstract]   [Full Text] [Related]  

  • 12. A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections.
    Mouton Y; Chidiac C; Humbert G; Leroy J; Veyssier P; Modai J; Bertrand A; Dellamonica P; Micoud M; Stahl JP
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():133-40. PubMed ID: 8150757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of ceftazidime in internal medicine in Japan.
    Shimada K
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():395-7. PubMed ID: 6225765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
    Huang CK; Chen YS; Lee SS; Lin WR; Tsai HC; Lin HH; Wann SR; Chen JY; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of severe systemic infections caused by multiple resistant organisms.
    Shah PM; Helm EB; Stille W
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():269-72. PubMed ID: 6252169
    [No Abstract]   [Full Text] [Related]  

  • 16. Cefepime.
    Hardin TC; Jennings TS
    Pharmacotherapy; 1994; 14(6):657-68. PubMed ID: 7885968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic and clinical study of cefpirome in children].
    Kohdera U; Woo M; Kino M; Kawasaki H; Suzukawa J; Nakamura M; Cho S; Hirabayashi Y; Higashino H; Kobayashi Y
    Jpn J Antibiot; 1991 Feb; 44(2):213-22. PubMed ID: 2041161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftazidime in clinical practice - a summary.
    Norrby SR
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():405-8. PubMed ID: 6352652
    [No Abstract]   [Full Text] [Related]  

  • 19. Do we need the third-generation cephalosporins?
    Neu HC
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():1-12. PubMed ID: 6501133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of cefpirome and ceftazidime in complicated urinary tract infections].
    Naide Y; Aso Y; Oshi M; Kumamoto Y; Hirose T; Machida T; Tsuchida S; Suzuki K; Orikasa S; Kawada Y
    Hinyokika Kiyo; 1991 Apr; 37(4):447-64. PubMed ID: 1892004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.